Skip to content

Effect of combined conservative therapies on clinical outcomes in patients with thumb base osteoarthritis: a randomised, controlled trial (COMBO)

Effect of combined conservative therapies on clinical outcomes in patients with thumb base osteoarthritis: a randomised, controlled trial (COMBO)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616000353493
Acronym
COMBO
Enrollment
204
Registered
2016-03-18
Start date
2016-05-26
Completion date
2018-07-20
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Osteoarthritis (OA) is a chronic disorder affecting the joints, most commonly involving the hands, knees and hips. In view of the strong association of OA with ageing, major concerns with the disease exist due to the continuous rise in the number of elderly. Pain is the most common symptom in addition to progressive difficulty or incapacity to perform daily activities. Among the different disease phenotypes, OA of the hands is a frequent condition, causing symptoms in up to 15% of the population worldwide. The subtype affecting the base of the thumb, in particular, is probably caused by mechanical factors overloading the joint in addition to genetic predisposition. Debilitating symptoms can occur in this subset of patients, including pain during daily activities such as writing and grasping, loss of hand function and joint stiffness. Due to modest effects, current non-surgical treatment frequently do not meet patients’ demand while surgery is only indicated in cases refractory to conservative therapy due to potential complications. For this reason, the need for novel studies addressing new conservative treatment strategies is emphasized by several reviews. Combination of therapies is often used in clinical practice but little evidence exists about its efficacy. Furthermore, the combination of non-pharmacological and pharmacological rehabilitation interventions has never been studied in the context of patients with thumb base OA. Therefore, the objective of this study is to investigate the effect of a combination of therapies compared to a control group receiving usual care. The new strategy will be delivered over a 6-week period and will consist of education about the disease and joint protection, exercises for the hand, splint for the base of the thumb and use of a topical NSAID. The control group will receive education and instructions on joint protection techniques alone.

Interventions

The intervention will be composed of four components: EDUCATION ABOUT THE DISEASE AND JOINT PROTECTION TECHNIQUES All participants will be provided with education about disease and joint protection techniques through an educational brochure delivered at baseline and through face-to-face meetings of approximately 30 minutes each with the study therapist at baseline and 2-week visit. The brochure and the visit will aim to provide information about the disease including: diagnosis, disease course,

The intervention will be composed of four components: EDUCATION ABOUT THE DISEASE AND JOINT PROTECTION TECHNIQUES All participants will be provided with education about disease and joint protection techniques through an educational brochure delivered at baseline and through face-to-face meetings of approximately 30 minutes each with the study therapist at baseline and 2-week visit. The brochure and the visit will aim to provide information about the disease including: diagnosis, disease course, objectives of treatment, self-management and instruction in joint protection techniques. The brochure was developed by a team of health professionals involved in this study (occupational therapists, physiotherapists and rheumatologists) with experience in the management of thumb base OA. The therapist will have a script to follow in order to be consistent with all participants regarding the joint protection advices. SPLINTS We will use prefabricated neoprene splints incorporating the base of the thumb and wrist and recommend its use during the activities of daily living (minimum of 4 hours/day) for 6 weeks, removing during rest, sleep, exercises, bathing and heat activities. EXERCISES The aim of the exercise programme in our study will be to optimize the range of motion (ROM) and joint stability, to increase strength and to prevent progression of deformities and loss of ROM. The programme will be consisted of five exercises: thumb opposition; paper tearing; line tracing on ball; objects collection with chopsticks and ball squeezing. Participants will receive instructions on how to do the exercises correctly through a supervised one-on-one 30 minute sessions with the study therapist at baseline and at two weeks after intervention commencement. They will be further instructed to perform individual unsupervised at-home sessions, three times per week for 6 weeks. Each exercise should be repeated 10 times during the first week. For the strength exercises (paper tearing and ball squeezing), the progression will be made by increasing the difficulty (e.g. tearing a thicker paper and squeezing the ball harder). For the remaining exercises, the number of repetitions will be increased, aiming for 12 repetitions during the second week and 15 repetitions for the following 4 weeks, if tolerated. Each home exercise session should last approximately 10 minutes. TOPICAL NSAIDS The usual prescription of topical NSAIDs for patients with hand OA involves the application of the medication over the affected joint three times a day. For the purpose of this trial, we will use Diclofenac diethylammonium gel (11.6 mg/g), a topical NSAID commonly used in clinical practice that has been studied in large, good quality trials with superiority over placebo . Participants will be instructed to administer the medication three times per day immediately prior to placing the splint for 6 weeks on a daily basis. In order to standardise the amount used, the participants will receive a small spatula with a permanent pen mark showing exactly how much product they should use. The advised amount corresponds with approximately 20 mg to be applied in an area of 40 cm2 as recommended by the drug instructions. The use of the medication for 6 weeks in this study and not for a shorter period of time is justifiable due to the chronic nature of OA. The topical NSAID will be free of charge. To monitor adherence to the treatments, participants from the intervention group will receive a diary and will be asked to record their use of splints and topical NSAIDs on a daily basis. In addition, the participants will be requested to report which exercises were performed and how frequently they were performed on a weekly basis. Participants will be asked to bring their diaries in for the re-assessment visits.

Sponsors

The University of Sydney a body corporate established pursuant to the University of Sydney Act 1989 represented and acting through the Dept of Rheumatology, Northern Clinical School
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

- Age greater than or equal to 40 years - Clinical diagnosis of OA in the first CMC joint in at least one hand - Chronic pain at the base of the thumb at least half of the days in the past month and at least 48 hours prior to the screening visit - Average VAS pain greater than or equal to 40 out of 100 (range, 0 – 100) over past 30 days - FIHOA scores greater than or equal to 6 (range, 0 - 30) - Radiographic evidence of OA in the first CMC joint read by a trained rheumatologist (KLG greater than or equal to 2)

Exclusion criteria

- Known diagnosis of crystal-related arthritis (e.g. gout, CPPD), autoimmune arthritis (e.g. rheumatoid arthritis, psoriatic arthritis), hemochromatosis or fibromyalgia - Hand surgery in the last 6 months or planning to undergo surgery in the next 6 months - Use of concomitant medications potentially directed at OA, unless at a stable dosage for at least 1 month for analgesics and NSAIDs or 3 months for slow acting symptomatic or structure modifying drugs - Intra-articular hyaluronic acid injection in the affected joint in the past 6 months - Intra-articular steroid injection in the affected joint in the past month - Significant injury to the affected joint in the past 6 months - Any other hand pathology that is likely to be contributing to the pain at the base of the thumb (e.g. scaphoid fracture, carpal tunnel syndrome, DeQuervain tendinopathy, trigger thumb, first CMC joint laxity or injury, joint infection, cubital tunnel syndrome, diabetic neuropathy, pain referred from the neck, pain following hand or wrist trauma or surgery) - Poor general health likely to interfere with compliance or assessments, judged by the investigator. - Known hypersensitivity to diclofenac - Current history of advanced renal failure - Past or current history of gastrointestinal ulceration, bleeding and/or perforation - Women who are pregnant or breastfeeding - Current use of any study interventions

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 3, 2026